Zolmitriptan Tablet, Film Coated
Product Images NDC 65862-914

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Zolmitriptan (NDC 65862-914). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Zolmitriptan Fig1)

A line chart titled 'Estimated Probability of Achieving Initial Headache Response' showing the probability of headache relief within 4 hours after dosing. The x-axis represents time from initial dose (0 to 4 hours), and the y-axis shows estimated probability of response (0% to 100%). Four lines compare placebo, Zolmitriptan 1 mg, 2.5 mg, and 5 mg doses, illustrating increasing response probability over time with higher doses reaching approximately 70-80% by 4 hours, while placebo remains lower.*

FDA Label Image

Figure 2 (Zolmitriptan Fig2)

A line graph showing the estimated probability of medication or rescue over time in hours from the initial dose, with curves for placebo and zolmitriptan doses of 1 mg, 2.5 mg, and 5 mg. The graph illustrates how the probability changes up to 24 hours after dosing.*

FDA Label Image

Package Label.principal Display Panel (2.5 mg Blister Carton)

Packaging label for Zolmitriptan Tablets, USP 2.5 mg film-coated tablets. The label indicates unit-dose packaging with 6 tablets (1 x 6) and is marked for prescription use only. The labeler is Aurobindo Pharma Limited, and the product is distributed by Aurobindo Pharma USA, Inc. The label includes NDC code 65862-914-69 and storage and usage information.*

FDA Label Image

Package Label.principal Display Panel (5 mg Blister Carton)

Packaging label for Zolmitriptan Tablets, USP 5 mg film-coated tablets. The package contains 3 unit-dose strips, each with 3 tablets. Label includes dosage strength 5 mg prominently displayed in red, NDC 65862-915-64, and is distributed by Aurobindo Pharma USA, Inc. The label states Rx only and includes storage and safety information.*

FDA Label Image

Zolmitriptan Chemical Structure (Zolmitriptan Str1)

Chemical structure diagram of zolmitriptan, showing its molecular framework with labeled atoms and rings as typically depicted for this active ingredient.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.